STOCK TITAN

Revelation Biosciences, Inc. (REVB) Net Income by Year

REVB

Revelation Biosciences, Inc. reported a net loss of $8.9M in fiscal year 2025. This represents an increase of 40.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Revelation Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$8.9M
YoY +40.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

REVB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$8.9M+40.7%-$15.0M-12405.6%-$120K+98.9%-$10.8MN/A-$1.6M-44718.6%-$4K

REVB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$3.3M-36.0%-$3.0M-46.7%N/A-$1.9M+14.9%-$2.4M+70.9%-$2.1M+23.5%N/A-$2.2M+14.7%-$8.4M-479.3%-$2.7M-143.5%N/A-$2.6M-124.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Revelation Biosciences, Inc. financials

Frequently Asked Questions

What was Revelation Biosciences, Inc.'s net income in fiscal year 2025?

Revelation Biosciences, Inc. reported a net loss of $8.9M in fiscal year 2025.

How fast is Revelation Biosciences, Inc.'s net income growing?

Revelation Biosciences, Inc. (REVB) net income rose by 40.7% year over year, from -$15.0M to -$8.9M in fiscal year 2025.

How has Revelation Biosciences, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Revelation Biosciences, Inc. (REVB) net income went from -$4K in fiscal year 2019 to -$8.9M in fiscal year 2025.

Revelation Biosciences, Inc. (REVB) reported -$3.3M in net income in Q2 2026. This represents a decrease of 36.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Revelation Biosciences, Inc. (REVB) reported on that line in every period on record.